Soleno Therapeutics, Inc. (SLNO)
53.01
0.00 (0.00%)
USD |
NASDAQ |
May 26, 16:00
Soleno Therapeutics Cash from Investing (Quarterly) : 37.98M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | -506.20M |
| Nektar Therapeutics | -350.79M |
| XOMA Royalty Corp. | 6.552M |
| Apellis Pharmaceuticals, Inc. (DELISTED) | 0.00 |
| Forian, Inc. (DELISTED) | 18.67M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 25.98M |
| Cash from Financing (Quarterly) | -1.043M |
| Free Cash Flow | 105.42M |
| Free Cash Flow Per Share (Quarterly) | 0.4888 |
| Free Cash Flow to Equity (Quarterly) | 24.22M |
| Free Cash Flow to Firm (Quarterly) | 27.10M |
| Free Cash Flow Yield | 3.74% |